Recently, a team led by Dr. Liu Bao, Deputy Director of the Department of Vascular Surgery at PUMCH, in collaboration with researchers from BGI·Research in Beijing, published their findings in Nature Cardiovascular Research, a Nature Research journal. This stu...

Recently, a collaborative study on the excretion pharmacokinetics of local anesthetics in breast milk among breastfeeding women, conducted by Associate Chief Physician Jing Quan from the Department of Dentistry and Researcher Wang Hongyun from the Clinical Pha...

Recently, the team led by Director Li Mengtao from the Department of Rheumatology at PUMCH, in collaboration with Researcher Yang Jun's team from Zhejiang University, revealed the dual mechanisms of the Activin A/ALK4 signaling pathway in Th17 cells and pulmon...

On May 15, 2025, velaglucerase beta for injection (CAN103), an innovative therapeutic drug for Gaucher disease developed through Phase I/II clinical trials led by PUMCH, received marketing approval from the National Medical Products Administration (NMPA) of Ch...